Express News | Boston Scientific Watchman Flx™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the Option Clinical Trial
Boston Scientific WATCHMAN FLX Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial
News On Axonics Inc. (AXNX) Now Under BSX
Weekly Buzz: Not All Parties Last Forever
Market Falls to End All-Time High Week | Wall Street Today
Boston Scientific Corporation (BSX) UBS Global Healthcare Conference (Transcript)
